Yubo Biotech Operating Expenses 2010-2024 | YBGJ

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Yubo Biotech operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Yubo Biotech operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$209.2B
Intuitive Surgical (ISRG)	$190.8B
Alcon (ALC)	$45.5B
IQVIA Holdings (IQV)	$39.4B
Edwards Lifesciences (EW)	$39.3B
IDEXX Laboratories (IDXX)	$35.8B
DexCom (DXCM)	$27.5B
Waters (WAT)	$22.6B
SONOVA HOLDING (SONVY)	$22.1B
STERIS (STE)	$21.9B
Hologic (HOLX)	$18.4B
Sysmex ADR (SSMXY)	$12.9B
Fresenius Medical Care AG KGaA (FMS)	$12.6B
Globus Medical (GMED)	$11.1B
Penumbra (PEN)	$9.3B
Teleflex (TFX)	$9.2B
Masimo (MASI)	$8.7B
Glaukos (GKOS)	$7.9B
PROCEPT BioRobotics (PRCT)	$5.1B
Integer Holdings (ITGR)	$4.7B
Inari Medical (NARI)	$3.1B
Veracyte (VCYT)	$3B
TransMedics (TMDX)	$3B
LivaNova (LIVN)	$2.8B
Nihon Kohden (NHNKY)	$2.6B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2.1B
Integra LifeSciences Holdings (IART)	$2B
RxSight (RXST)	$1.9B
Alphatec Holdings (ATEC)	$1.4B